HOME › DRUGS › DIFLUNISAL
ACTIVE SUBSTANCE / INN

DIFLUNISAL

Brand name(s): DOLOBID, Attrogy, DIFLUNISAL
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA073673
NDA018445
ACTIVE SUBSTANCE
Diflunisal
REGULATORS
FDA · EMA
SPONSORS / MAH
TEVA, MERCK, DASTECH INTL
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DIFLUNISALANDA073563DASTECH INTLDiscontinued
DIFLUNISALANDA073673TEVAPrescription
DOLOBIDNDA018445MERCKDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AttrogyPurpose Pharma International ABAuthorised17/07/2025Amyloid Neuropathies, Familial

FULL INTELLIGENCE ON DIFLUNISAL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →